In 2008, a 63-year-old woman presented to the Emergency Department at an outside institution with a serum calcium level of 15 mg/dl detected on routine blood work. Further investigation revealed a right inferior parathyroid adenoma, for which she underwent a focused parathyroidectomy. Three years later she was found to have recurrent hypercalcemia, and she was taken to the OR for removal of her left superior and left inferior parathyroid glands. Both glands showed hyperplastic parathyroid tissue without evidence of parathyroid carcinoma.
Parathyroid carcinoma in a patient with three prior parathyroid adenomas In 2008, a 63-year-old woman presented to the Emergency Department at an outside institution with a serum calcium level of 15 mg/dl detected on routine blood work. Further investigation revealed a right inferior parathyroid adenoma, for which she underwent a focused parathyroidectomy. Three years later she was found to have recurrent hypercalcemia, and she was taken to the OR for removal of her left superior and left inferior parathyroid glands. Both glands showed hyperplastic parathyroid tissue without evidence of parathyroid carcinoma.
In 2015, the patient again presented with severe hypercalcemia and underwent a revision parathyroid exploration. The remaining right superior parathyroid was adherent to the thyroid and partially intrathyroidal, so a hemithyroidectomy was performed to achieve complete removal of the parathyroid gland.
To avoid postoperative hypoparathyroidism after removal of the patient's only remaining parathyroid gland, a portion of the right superior gland was minced and implanted into her right brachioradialis muscle. However, final pathology showed parathyroid carcinoma with invasion of the thyroid gland and skeletal muscle (figure 1). Therefore, she underwent a wide local excision of the implanted tissue. She was referred to our clinic to discuss the need for further surgery.
Parathyroid carcinoma is an exceedingly rare disease, representing less than 1% of all cases of primary hyperparathyroidism and less than 0.005% of all cancers. 1 The major risk factors for developing parathyroid carcinoma are hereditary cancer predisposition syndromes, including multiple endocrine neoplasia type 1 (MEN-1), MEN-2A, and hyperparathyroidism-jaw tumor syndrome. Other potential risk factors include parathyroid adenoma, prior radiation exposure, and secondary or tertiary hyperparathyroidism; however, the absolute contribution of these factors to parathyroid carcinoma risk remains controversial. 2 Typically, parathyroid carcinoma presents with severe hypercalcemia (≥14 mg/dl), a palpable neck mass, markedly elevated intact parathyroid hormone levels, renal involvement, and osteopenia or osteoporosis. 2,3 Accord- THyROID AND PARATHyROID CLINIC ingly, some authors argue that patients presenting with these symptoms should be presumed to have parathyroid carcinoma until proven otherwise. 2 Imaging studies, including ultrasound and technetium-99m sestamibi, may be used to localize disease, but these studies are generally not useful for identifying malignancy. 4 Fine-needle aspiration is contraindicated because of its inability to distinguish parathyroid carcinoma parathyroid carcinoma (B) , as demonstrated by the photomicrographs from the patient described in this report. The parathyroid carcinoma shown here has slightly enlarged nuclei with moderate nuclear clearing, although these changes are not specific for parathyroid carcinoma and may be seen in benign glands.
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from benign disease and the risk of seeding tumor along the biopsy tract (figure 2). 3 Parathyroid carcinomas are distinguished from adenomas by invasion of surrounding tissues (figure 1), and therefore the final diagnosis is frequently made during surgery or upon pathology review. 2 Treatment of parathyroid carcinoma is surgical resection with microscopically clear margins, as the tumors are often chemotherapy-and radiation-resistant. 2 Patients with presumed parathyroid carcinoma should also undergo fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) scanning of the chest and abdomen to identify metastatic disease. 2 Disease involves proximal lymph nodes in 15 to 30% of cases and has undergone distant metastasis in 33%, most commonly to the lung; other common sites of metastasis include the liver and bone. 3 Overall 5-year survival for parathyroid carcinoma is 85%, but the disease recurs in up to 50% of patients, leading to multiple operations with an increased risk of complications. 2 After reviewing this case at the tumor board, it was decided that further surgery was not indicated given the patient's normal parathyroid hormone (PTH) and serum calcium levels. Routine blood tests and PTH levels will be used to monitor for disease recurrence.
